Injectable bulking agents for treating faecal incontinence

British Journal of Surgery

Volumn 92, Issue 5, 2005, Pages 521-527

  Vaizey, C J ^a   Kamm, M A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BULKING AGENT; COLLAGEN GEL; POLITEF;

ANUS SPHINCTER; FECES INCONTINENCE; PRIORITY JOURNAL; REVIEW; SAFETY; URINE INCONTINENCE;

BIOCOMPATIBLE MATERIALS; COLLAGEN; FECAL INCONTINENCE; HUMANS; INJECTIONS; POLYMERS;

EID: 18844443388     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4997     Document Type: Review

References (57)

1. Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. JAMA 1995; 274: 559-561.
2. Matzel KE, Kamm MA, Stosser M, Baeten CG, Christiansen J, Madoff R et al. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet 2004; 363: 1270-1276.
3. Efron JE, Corman ML, Fleshman J, Barnett J, Nagle D, Birnbaum E et al. Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca procedure) for the treatment of fecal incontinence. Dis Colon Rectum 2003; 46: 1606-1618.
4. Morgan R, Patel B, Beynon J, Carr ND. Surgical management of anorectal incontinence due to internal anal sphincter deficiency. Br J Surg 1997; 84: 226-230.
5. Shafik A. Polytetrafluoroethylene injection for the treatment of partial fecal incontinence. Int Surg 1993; 78: 159-161.
6. Shafik A. Perianal injection of autologous fat for treatment of sphincteric incontinence. Dis Colon Rectum 1995; 38: 583-587.
7. Bernardi C, Favetta U, Pescatori M. Autologous fat injection for treatment of fecal incontinence: manometric and echographic assessment. Plast Reconstr Surg 1998; 102: 1626-1628.
8. Kumar D, Benson MJ, Bland JE. Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence. Br J Surg 1998; 85: 978-979.
9. Malouf AJ, Vaizey CJ, Norton CS, Kamm MA. Internal anal sphinter augmentation for fecal incontinence using injectable silicone material. Dis Colon Rectum 2001; 44: 595-600.
10. Kenefick NJ, Vaizey CJ, Malouf AJ, Norton CS, Marshall M, Kamm MA. Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction. Gut 2002; 51: 225-228.
11. Davis K, Kumar D, Poloniecki J. Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence. Aliment Pharmacol Ther 2003; 18: 237-243.
12. Weiss EG, Efron JE, Nogueras JJ, Wexner SD. Submucosal injection of carbon-coated beads is a successful and safe office-based treatment for fecal incontinence. American Society of Colon and Rectal Surgeons Chicago, June 2002.
13. Feretis C, Benakis P, Dailianas A, Dimopoulos C, Mavrantonis C, Stamou KM et al. Implantation of microballoons in the management of fecal incontinence. Dis Colon Rectum 2001; 44: 1605-1609.
14. Pycha A, Klinger CH, Haitel A, Heinz-Peer G, Marberger M. Implantable microballoons: an attractive alternative in the management of intrinsic sphincter deficiency. Eur Urol 1998; 33: 469-475.
15. van Kerrebroeck P, ter Meulen F, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A. Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res 2003; 30: 356-362.
16. Malizia AA, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984; 251: 3277-3281.
17. Berg S. Polytef augmentation urethroplasty. Correction of surgically incurable urinary incontinence by injection technique. Arch Surg 1973; 107: 379-381.
18. Politano VA. Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1982; 127: 439-442.
19. Menard S, Porta GD. Incidence, growth and antigenicity of fibrosarcomas induced by Teflon disc in mice. Tumori 1976; 62: 565-573.
20. Witherspoon P, Bryson G, Wright DM, Reid R, O'Dwyer PJ. Carcinogenic potential of commonly used hernia repair prostheses in an experimental model. Br J Surg 2004; 91: 368-372.
21. Currie I, Drutz HP, Deck J, Oxorn D. Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8: 377-380.
22. Sweat SD, Lightener DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 1999; 161: 93-96.
23. Yoon SS, Chang DI, Chung KC. Acute fatal stroke immediately following autologous fat injection into the face. Neurology 2003; 61: 1151-1152.
24. Havas TE, Priestley KJ. Autologous fat injection laryngoplasty for unilateral vocal fold paralysis. Aust N Z J Surg 2003; 73: 938-943.
25. Bertossi D, Zancanaro C, Trevisiol L, Albanese M, Ferrari F, Nocini PF. Lipofilling of the lips: ultrastructural evaluation by transmission electron microscopy of injected adipose tissue. Arch Facial Plast Surg 2003; 5: 392-398.
26. Haab F, Zimmern PE, Leach GE. Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections. J Urol 1997; 157: 1283-1286.
27. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol 2000; 165: 153-158.
28. Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR. Periurethral collagen injection: a long-term follow-up study. BJU Int 1999; 84: 966-971.
29. Swami S, Batista JE, Abrams P. Collagen for female genuine stress incontinence after a minimum 2-year follow-up. Br J Urol 1997; 80: 757-761.
30. Pickard R, Reaper J, Wyness L, Cody DJ, McClinton S, N'Dow J. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2003; (2)CD003881.
31. Smith DP, Kaplan WE, Oyasu R. Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 1994; 152: 1221-1224.
32. Henly DR, Barrett DM, Weiland TL, O'Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 1995; 153: 2039-2043.
33. Nijhuis PH, van den Bogaard TE, Daemen MJ, Baeten CG. Perianal injection of polydimethylsiloxane (Bioplastique implants) paste in the treatment of soiling: pilot study in rats to determine migratory tendency and locoregional reaction. Dis Colon Rectum 1998; 41: 624-629.
34. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000; 342: 781-790.
35. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease - a comprehensive review. Autoimmunity 2003; 36: 193-197.
36. ter Meulen PH, Berghmans LC, van Kerrebroeck PE. Sytematic review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol 2003; 44: 573-582.
37. Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 2001; 166: 1350-1353.
38. Lightner D, Calvosa C, Andersen R, Klimberg I, Brito CG, Snyder J et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 2001; 58: 12-15.
39. Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow up. J Urol 2004; 171: 1152-1155.
40. Sklar JA, White SM. Radiance FN: a new soft tissue filler. Dermatol Surg 2004; 30: 764-768.
41. Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 2001; 57: 434-438.
42. 125Iodine labeled dextranomer based implant into the rabbit bladder. J Urol 1997; 158: 1937-1941.
43. Stenberg A, Larsson G, Johnson P, Heimer G, Ulmsten U. DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short team results. Acta Obstet Gynecol Scand 1999; 78: 436-442.
44. Stenberg A, Larsson E, Lackgren G. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 2003; 169: 1109-1113.
45. Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 2001; 170: 1541-1544.
46. Stenberg AM, Larsson G, Johnson P. Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 335-338.
47. Saray A. Porcine dermal collagen (Permacol) for facial contour augmentation: preliminary report. Aesthetic Plast Surg 2003; 27: 368-375.
48. Bano F, Barrington JW, Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct [September 18; Epub ahead of print].
49. Breiting V, Aasted A, Jorgensen A, Opitz P, Rosetzsky A. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesthetic Plast Surg 2004; 28: 45-53.
50. de Cassia Novaes W, Berg A. Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study. Aesthetic Plast Surg 2003; 27: 376-380.
51. Cannon TW, Lee JY, Somogyi G, Pruchnic R, Smith CP, Huard J et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 2003; 62: 958-963.
52. Strasser H, Marksteiner R, Margreiter E, Pinggera GM, Mitterberger M, Fritsch H et al. Stem cell therapy for urinary incontinence. Urologe A 2004; 43: 1237-1241.
53. Kershen RT, Dmochowski RR, Appell RA. Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urol Clin North Am 2002; 29: 559-574.
54. Johnson DA. Enteryx implant for gastroesophageal reflux disease. Curr Treat Options Gastroenterol 2005; 8: 51-57.
55. Thornton AJ, Alsberg E, Hill EE, Mooney DJ. Shape retaining injectable hydrogels for minimally invasive bulking. J Urol 2004; 172: 763-768.
56. Madjar S, Covington-Nichols C, Secrest CL. New periurethral bulking agent for stress urinary incontinence: modified technique and early results. J Urol 2003; 170: 2327-2329.
57. Lightner DJ. Review of the available urethral bulking agents. Curr Opin Urol 2002; 12: 333-338.